Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 28.42.
Forward PE Ratio (28.42) = Close Price ($1325.52) / Consensus Forward EPS ($47.33)
FORWARD PE RATIO
28.42
SECTOR MEDIAN · HEALTHCARE
20.01
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
+42.03%
vs the sector median at left
Mettler-Toledo International Inc.
Market Cap
$26.79B
Forward PE Ratio
28.42
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Mettler-Toledo International Inc. (MTD) | $26.79B | 28.42 |
| Labcorp Holdings Inc. (LH)vs › | $26.64B | 17.81 |
| Quest Diagnostics Incorporated (DGX)vs › | $25.99B | 21.19 |
| Incyte Corporation (INCY)vs › | $25.22B | 33.69 |
| BioNTech SE (BNTX)vs › | $24.78B | N/A |
| Medline Inc. (MDLN)vs › | $29.33B | 24.51 |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.79B | 37.91 |
| Waters Corporation (WAT)vs › | $30.13B | 28.09 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.16B | 13.98 |
| Zoetis Inc. (ZTS)vs › | $30.86B | 12.12 |
Trailing P/E
30.2
reported TTM EPS
Forward P/E
28.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $47.33 implies +6.4% EPS growth vs the reported trailing $44.49.
At today's $1325.52 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $47.33 | $47.23 – $47.53 | 8 | 28.0x |
| 2027-12-31 | $51.65 | $51.22 – $51.92 | 8 | 25.7x |
| 2028-12-31 | $57.43 | $56.10 – $59.42 | 4 | 23.1x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute